Q fever vaccines: Present status and application in man

Ascher, 1983, Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans, J. Infect. Dis., 148, 214, 10.1093/infdis/148.2.214 Baca, 1983, Q fever and Coxiella burnetii: a model for host-parasite interactions, Microbiol. Rev., 42, 127, 10.1128/MMBR.47.2.127-149.1983 Bell, 1964, Recurrent reaction at site of Q fever vaccination in a sensitized person, Milit. Med., 7, 591, 10.1093/milmed/129.7.591 Bell, 1964, Serologic and skin test response after Q fever vaccination by the intracutaneous route, J. Immunol., 93, 403, 10.4049/jimmunol.93.3.403 Brezina, 1961, Extraction of Coxiella burnetii phase I antigen by means of trichloroacetic acid, Acta virol., 5, 193 Brezina, 1974, Q fever chemovaccine for human use, Acta virol., 18, 269 Cracea, 1973, Immunization in man with a soluble Q fever vaccine, Arch. Roum. Path. Exp. Microbiol., 32, 45 Cracea, 1977, Q fever soluble vaccine effects in Coxiella burnetii sensitized humans, Zbl. Bakt. Hyg., I. Abt. Orig. A, 238, 413 Damrow, 1985, Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii, Infect. Immun., 47, 149, 10.1128/IAI.47.1.149-156.1985 Fiset, 1970, Review of status of Q fever vaccine studies, Commission on Rickettsial Diseases of the Armed Forces Epidemiological Board Genig, 1965, Experience on the mass immunization of humans with the M-44 vaccine against Q fever. 1. Subcutaneous method of immunization, Vopr. Virusol., 10, 319 Hackstadt, 1986, Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates, Infect. Immun., 52, 337, 10.1128/IAI.52.1.337-340.1986 Johnson, 1977, Lesions in guinea pigs infected with Coxiella burnetii strain M-44, J. Infect. Dis., 135, 995, 10.1093/infdis/135.6.995 Kazár, 1985, Relationship between delayed hypersensitivity reaction and resistance to virulent challenge in mice immunized with different Coxiella burnetii antigenic preparations, 282 Kazár, 1973, Testing in various systems of the neutralizing capacity of Q fever immune sera, Acta virol., 17, 79 Kazár, 1982, Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia, Bull. Wld Hlth Org., 60, 389 Kazár, 1983, Induction of splenomegaly in mice by killed Coxiella burnetii cells, Acta virol., 27, 65 Kazár, 1983, Experiences with vaccination of humans to Q fever in Czechoslovakia, Bratisl. lek. Listy, 80, 31 Kazár, 1984, The value of skin test in Q fever convalescents and vaccinees as indicator of antigen exposure and inducer of antibody recall, Acta virol., 28, 134 Kazár, 1986, Onset and duration of immunity in guinea pigs and mice induced by different types of Q fever vaccine, Acta virol., 30, 499 Lackman, 1962, Intradermal sensibility testing in man with a purified vaccine for Q fever, Amer. J. Publ. Hlth., 52, 87, 10.2105/AJPH.52.1.87 Luoto, 1963, Q fever vaccination of human volunteers. 1. Serologic and skin test response following subcutaneous injection, Amer. J. Hyg., 78, 1 Marmion, 1984, Vaccine prophylaxis of abattoir-associated Q fever, Lancet, II, 1411, 10.1016/S0140-6736(84)91617-9 Ormsbee, 1964, The influence of phase on the protective potency of Q fever vaccine, J. Immunol., 92, 404, 10.4049/jimmunol.92.3.404 Samuel, 1985, Correlation of plasmid type and disease caused by Coxiella burnetii, Infect. Immun., 49, 775, 10.1128/IAI.49.3.775-779.1985 Schramek, 1978, Rickettsial endotoxic lipopolysaccharides, 79 Turck, 1986, Chronic Q fever, 1255 Vodkin, 1986, Genetic heterogeneity among isolates of Coxiella burnetii, J. Gen. Microbiol., 132, 455 Votruba, 1985, Comparison of protective effects of different Coxiella burnetii antigenic preparation against aerosol challenge in guinea pigs, 289 Williams, 1982, Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice, Infect. Immun., 35, 1091, 10.1128/IAI.35.3.1091-1102.1982 Williams, 1986, Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10ScN mice, Infect. Immun., 51, 851, 10.1128/IAI.51.3.851-858.1986 Worswick, 1985, Antibody response in acute and chronic Q fever and in subjects vaccinated against Q fever, J. Med. Microbiol., 19, 281, 10.1099/00222615-19-3-281